CALGB


Also found in: Acronyms.

CALGB

Cancer and Leukemia Group B. A national (US) clinical research group sponsored by the NCI, with its central office headquartered at the University of Chicago and its statistical centre located at Duke University.
References in periodicals archive ?
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of CALGB.
A 28-year-old man with leukocytosis and anemia
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: A CALGB randomized trial of efficacy, quality of life and cost-effectiveness.
Cancer de pulmon no microcitico: quimioterapia y otros tratamientos sistemicos
In its simplest sense, that is what the CALGB 9251 protocol is.
CA and Leukemia Group B 9251 protocol
Publication in the New England Journal of Medicine of three phase III REVLIMID trials in newly diagnosed multiple myeloma (MM-015, IFM 2005-02, and CALGB 100104).
Celgene Reports Second Quarter 2012 Operating and Financial Results
The CHMP recommendation was based on the results of two cooperative group-led studies, CALGB 10010410 and IFM 2005-0211:
Celgene Receives Positive CHMP Opinion to Expand Revlimid (Lenalidomide) Indication
Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712.
Outcomes of first line chemotherapy in patients with chronic lymphocytic leukemia
Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
The shifting paradigms of diet and cancer
Meyerhardt and his group published an analysis of data from a National Cancer Institute-sponsored study called CALGB 89803 that involved 1,264 patients with stage II colon cancer, randomized to treatment with 5-fluorouracil and leucovorin with or without irinotecan following surgical resection.
Physical activity reduces colon cancer's toll
cyclophosphamide-epirubicin-fluorouracil)] and CALGB 8541 trials all demonstrated anthracycline sensitivity in HER2-amplified tumours.
Chemosensitivity (and resistance) in breast cancer
The phase III CALGB 80405 trial in which patients are randomized to FOLFIRI/FOLFOX plus cetuximab or bevacizumab or cetuximab and bevacizumab [63] will hopefully answer this question and establish which targeted agent is the preferred combination partner.
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel
The practice is affiliated with national Clinical Study protocol groups, CALGB,(Cancer and Leukemia Group B), and NSABP(National Surgical Adjuvant Breast and Bowel Project), offering patients the opportunity of national clinical studies, through The Vermont Regional Cancer Center.
VSNA INC Convention 2007: ethics: quality care
The first of the studies, CALGB 8541, began accruing patients 20 years ago.
Refined chemo benefits ER-negative patients
Medical browser ?
Full browser ?